Literature DB >> 25319555

Prodromal Symptoms in Patients with Bisphosphonate-Associated Atypical Fractures of the Femur.

Mohammad Kharazmi1, Karl Michaëlsson, Pär Hallberg.   

Abstract

Symptoms have been reported to precede bisphosphonate-associated atypical fractures (AFs) of the femoral shaft. We aimed to determine the frequency and clinical characteristics of such prodromal symptoms. We searched the Swedish national database of spontaneously reported adverse drug reactions for all cases of AF associated with bisphosphonates from January 2006 to March 2013. To confirm diagnostic accuracy and to characterize and determine the frequency of any prodromal symptoms we retrieved copies of medical journals and radiographs for patients who consented to participate in the study. The frequency of prodromal symptoms was compared with that of patients where information was based only on narratives from the adverse drug reaction case reports. A total of 45 reports of AF were identified. We were able to obtain medical records and x-rays for 21 cases and diagnostic accuracy was confirmed for all. Medical records revealed prodromal symptoms in 86 % (n = 18), most commonly pain in the ipsilateral thigh (14 out of 18 patients) preceding the fracture for weeks or longer. Awareness of such symptoms may facilitate early diagnosis and possible prevention of the AF.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25319555     DOI: 10.1007/s00774-014-0611-9

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  25 in total

1.  Atypical femoral fractures during prolonged use of bisphosphonates: short-term responses to strontium ranelate and teriparatide.

Authors:  N N C Carvalho; L A Voss; M O P Almeida; C L Salgado; F Bandeira
Journal:  J Clin Endocrinol Metab       Date:  2011-07-13       Impact factor: 5.958

2.  Bilateral low-energy sequential femoral shaft fractures in patients on long-term bisphosphonate therapy.

Authors:  Selami Çakmak; Mahir Mahiroğulları; Kenan Keklikçi; Enes Sarı; Baran Erdik; Osman Rodop
Journal:  Acta Orthop Traumatol Turc       Date:  2013       Impact factor: 1.511

3.  Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib.

Authors:  T Mashiba; T Hirano; C H Turner; M R Forwood; C C Johnston; D B Burr
Journal:  J Bone Miner Res       Date:  2000-04       Impact factor: 6.741

4.  Bisphosphonate use and atypical fractures of the femoral shaft.

Authors:  Jörg Schilcher; Karl Michaëlsson; Per Aspenberg
Journal:  N Engl J Med       Date:  2011-05-05       Impact factor: 91.245

5.  Teriparatide, vitamin D, and calcium healed bilateral subtrochanteric stress fractures in a postmenopausal woman with a 13-year history of continuous alendronate therapy.

Authors:  Stephen J Gomberg; Rosanna L Wustrack; Nicola Napoli; Claude D Arnaud; Dennis M Black
Journal:  J Clin Endocrinol Metab       Date:  2011-03-23       Impact factor: 5.958

6.  Femoral insufficiency fractures associated with prolonged bisphosphonate therapy.

Authors:  Joseph D Isaacs; Louis Shidiak; Ian A Harris; Zoltan L Szomor
Journal:  Clin Orthop Relat Res       Date:  2010-08-31       Impact factor: 4.176

7.  Bisphosphonate treatment suppresses not only stochastic remodeling but also the targeted repair of microdamage.

Authors:  J Li; T Mashiba; D B Burr
Journal:  Calcif Tissue Int       Date:  2001-11       Impact factor: 4.333

Review 8.  Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research.

Authors:  Elizabeth Shane; David Burr; Bo Abrahamsen; Robert A Adler; Thomas D Brown; Angela M Cheung; Felicia Cosman; Jeffrey R Curtis; Richard Dell; David W Dempster; Peter R Ebeling; Thomas A Einhorn; Harry K Genant; Piet Geusens; Klaus Klaushofer; Joseph M Lane; Fergus McKiernan; Ross McKinney; Alvin Ng; Jeri Nieves; Regis O'Keefe; Socrates Papapoulos; Tet Sen Howe; Marjolein C H van der Meulen; Robert S Weinstein; Michael P Whyte
Journal:  J Bone Miner Res       Date:  2013-10-01       Impact factor: 6.741

9.  Atypical femur fractures: 81 individual personal histories.

Authors:  Jennifer P Schneider; William B Hinshaw; Christina Su; Phyllis Solow
Journal:  J Clin Endocrinol Metab       Date:  2012-10-17       Impact factor: 5.958

10.  Bisphosphonate-associated atypical fracture of the femur: Spontaneous healing with drug holiday and re-appearance after resumed drug therapy with bilateral simultaneous displaced fractures--a case report.

Authors:  Ken Lee Puah; Mann Hong Tan
Journal:  Acta Orthop       Date:  2011-05-11       Impact factor: 3.717

View more
  5 in total

1.  Bone Structure and Turnover Status in Postmenopausal Women with Atypical Femur Fracture After Prolonged Bisphosphonate Therapy.

Authors:  Shijing Qiu; George W Divine; Saroj Palnitkar; Pooja Kulkarni; Trent S Guthrie; Mahalakshmi Honasoge; Sudhaker D Rao
Journal:  Calcif Tissue Int       Date:  2016-12-24       Impact factor: 4.333

2.  Atypical femoral fractures in Italy: a retrospective analysis in a large urban emergency department during a 7-year period (2007-2013).

Authors:  Mario Pedrazzoni; Andrea Giusti; Giuseppe Girasole; Barbara Abbate; Ignazio Verzicco; Gianfranco Cervellin
Journal:  J Bone Miner Metab       Date:  2016-11-09       Impact factor: 2.626

3.  Risk of atypical femoral fracture during and after bisphosphonate use.

Authors:  Jörg Schilcher; Veronika Koeppen; Per Aspenberg; Karl Michaëlsson
Journal:  Acta Orthop       Date:  2015-01-13       Impact factor: 3.717

4.  Importance and Difficulty of Differentiating BMA-induced AFF Prodromal Symptoms from Hormonal Therapy-related Femoral Pain.

Authors:  Shuji Ota; Toru Tokizaki; Masakazu Sugimoto; Ryosuke Ochiai; Terunobu Haruyama; Masashi Ishihara; Maika Natsume; Yoko Fukasawa; Takahiko Sakamoto; Shigeru Tanzawa; Ryo Usui; Takeshi Honda; Yasuko Ichikawa; Kiyotaka Watanabe; Hirotaka Kawano; Nobuhiko Seki
Journal:  Intern Med       Date:  2019-11-22       Impact factor: 1.271

5.  Incomplete Atypical Femoral Fracture Treated by Prophylactic Intramedullary Nail Fixation: A Case Series.

Authors:  Tomohiko Sakuda; Osamu Omoto; Takahiko Hamasaki; Nobukazu Okimoto; Nobuo Adachi
Journal:  Cureus       Date:  2022-02-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.